ArticleHead and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings2025
Benchmark of Deep Encoder-Decoder Architectures for Head and Neck Tumor Segmentation in Magnetic Resonance Images: Contribution to the HNTSMRG Challenge.
Article in Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Overview of the Head and Neck Tumor Segmentation for Magnetic Resonance Guided Applications (HNTS-MRG) 2024 Challenge.Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Radiation therapy is one of the most frequently applied cancer treatments worldwide, especially in the context of head and neck cancer. Today, MRI-guided radiation therapy planning is becoming increasingly popular due to good soft tissue contrast, lack of radiation dose delivered to the patient, and the capability of performing functional imaging. However, MRI-guided radiation therapy requires segmenting of the cancer both before and during radiation therapy. So far, the segmentation was often performed manually by experienced radiologists, however, recent advances in deep learning-based segmentation suggest that it may be possible to perform the segmentation automatically. Nevertheless, the task is arguably more difficult when using MRI compared to e.g. PET-CT because even manual segmentation of head and neck cancer in MRI volumes is challenging and time-consuming. The importance of the problem motivated the researchers to organize the HNTSMRG challenge with the aim of developing the most accurate segmentation methods, both before and during MRI-guided radiation therapy. In this work, we benchmark several different state-of-the-art segmentation architectures to verify whether the recent advances in deep encoder-decoder architectures are impactful for low data regimes and low-contrast tasks like segmenting head and neck cancer in magnetic resonance images. We show that for such cases the traditional residual UNetbased method outperforms (DSC = 0.775/0.701) recent advances such as UNETR (DSC = .617/0.657), SwinUNETR (DSC = 0.757/0.700), or SegMamba (DSC = 0.708/0.683). The proposed method (lWM team) achieved a mean aggregated Dice score on the closed test set at the level of 0.771 and 0.707 for the pre- and mid-therapy segmentation tasks, scoring 14th and 6th place, respectively. The results suggest that proper data preparation, objective function, and preprocessing are more influential for the segmentation of head and neck cancer than deep network architecture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.